Loading chart…
CLOSED
Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It produces, develops, and markets various branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs).
Lupin Limited (LUPIN) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The LUPIN share price is ₹2,016.50 (+1.43% today), with a market capitalisation of ₹922B and a price-to-earnings (P/E) ratio of 17.8. MarketRipple tracks the LUPIN investment thesis, the ripple-chain impact of market events on Lupin Limited, and the Healthcare sector outlook.
Open
₹1,997.40
High
₹2,036.50
Low
₹1,991.00
Prev. Close
₹1,988.10
52W High
₹2,529.50
52W Low
₹1,892.90
Day range
₹1,991.00–₹2,036.50
52-week range
₹1,892.90–₹2,529.50
Volume
332K
P/E
17.8
ROE
23.9%
D/E
0.29
Margin
16.9%
Lupin Limited (NSE: LUPIN) is currently trading at ₹2,016.50 (+1.43%).
Lupin Limited's market capitalization is ₹922B.
Lupin Limited's price-to-earnings (P/E) ratio is 17.8.
Lupin Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Lupin Limited currently reads neutral, based on 36 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.